Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Bragadiru – page 10

671 clinical trials in Bragadiru, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Bragadiru at a glance
671
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

671 trials in Bragadiru

Open in trial search

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Eikon Therapeutics Inc.

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Arsenic Trioxide
  • Sponsor:Quetzal Therapeutics LLC

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Enicepatide
  • Sponsor:F. Hoffmann-La Roche AG

Asthma

Recruiting

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:GB-0895
  • Sponsor:Generate Biomedicines Inc.

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.

BMN 333 Versus Vosoritide in Children With Achondroplasia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:BMN 333
  • Sponsor:Biomarin Pharmaceutical Inc.

FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:FWY003 tosilate
  • Sponsor:Novartis Pharma AG

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Bragadiru

What the registry says about research in the country

01 Respiratory Disease Management

Innovative research focusing on moderate to severe asthma treatments, evaluating new inhaler formulations and their safety profiles. Studies aim to improve bronchodilation and reduce exacerbations in patients following GINA guidelines.

  • Asthma Control Studies
  • Inhaler Technology Assessment
  • Bronchodilation Research

Multiple trials examining maintenance therapy optimization for better patient outcomes.

02 COPD Research Initiatives

Comprehensive studies exploring chronic obstructive pulmonary disease treatments, including evaluation of triple combination therapies and novel biological agents for moderate to severe cases.

  • Lung Function Enhancement
  • Exacerbation Prevention
  • Long-term Safety Studies

Focus on improving quality of life for patients with chronic respiratory conditions.

03 Advanced Therapeutic Solutions

Investigation of targeted treatments for severe eosinophilic asthma and development of innovative rescue medications. Research includes long-term efficacy studies of biological treatments.

  • Biological Therapy Evaluation
  • Rescue Medication Development
  • Extended Duration Trials

Emphasis on personalized treatment approaches for specific patient populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.